Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 50 |
| List of Tables | 44 | 7 |
| List of Figures | 51 | 1 |
| Introduction | 52 | 1 |
| Global Markets Direct Report Coverage | 52 | 1 |
| Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Overview | 53 | 1 |
| Therapeutics Development | 54 | 2 |
| Pipeline Products for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Overview | 54 | 1 |
| Pipeline Products for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Comparative Analysis | 55 | 1 |
| Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Therapeutics under Development by Companies | 56 | 17 |
| Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Therapeutics under Investigation by Universities/Institutes | 73 | 3 |
| Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Pipeline Products Glance | 76 | 4 |
| Late Stage Products | 76 | 1 |
| Clinical Stage Products | 77 | 1 |
| Early Stage Products | 78 | 1 |
| Unknown Stage Products | 79 | 1 |
| Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Products under Development by Companies | 80 | 30 |
| Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Products under Investigation by Universities/Institutes | 110 | 4 |
| Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Companies Involved in Therapeutics Development | 114 | 200 |
| 4SC AG | 114 | 1 |
| AB Science SA | 115 | 1 |
| AbbVie Inc. | 116 | 1 |
| Acetylon Pharmaceuticals, Inc. | 117 | 1 |
| Actinium Pharmaceuticals, Inc. | 118 | 1 |
| ADC Therapeutics Sarl | 119 | 1 |
| Advenchen Laboratories, LLC | 120 | 1 |
| Aeglea BioTherapeutics, Inc. | 121 | 1 |
| Affichem SA | 122 | 1 |
| Agios Pharmaceuticals, Inc. | 123 | 1 |
| AIMM Therapeutics B.V. | 124 | 1 |
| Akinion Pharmaceuticals AB | 125 | 1 |
| Altor BioScience Corporation | 126 | 1 |
| Amgen Inc. | 127 | 1 |
| Antigen Express, Inc. | 128 | 1 |
| Antisense Therapeutics Limited | 129 | 1 |
| APIM Therapeutics AS | 130 | 1 |
| Aprea AB | 131 | 1 |
| arGEN-X BV | 132 | 1 |
| Ariad Pharmaceuticals, Inc. | 133 | 1 |
| Arno Therapeutics, Inc. | 134 | 1 |
| Arog Pharmaceuticals, Inc. | 135 | 1 |
| Array BioPharma Inc. | 136 | 1 |
| Astellas Pharma Inc. | 137 | 1 |
| Asterias Biotherapeutics, Inc. | 138 | 1 |
| Astex Pharmaceuticals, Inc. | 139 | 1 |
| AstraZeneca Plc | 140 | 1 |
| Atara Biotherapeutics, Inc. | 141 | 1 |
| Athenex, Inc. | 142 | 1 |
| Aurigene Discovery Technologies Limited | 143 | 1 |
| AVEO Pharmaceuticals, Inc. | 144 | 1 |
| Bayer AG | 145 | 1 |
| BCI Pharma | 146 | 1 |
| Bellicum Pharmaceuticals, Inc. | 147 | 1 |
| BerGenBio AS | 148 | 1 |
| Bio-Cancer Treatment International Limited | 149 | 1 |
| Bio-Path Holdings, Inc. | 150 | 1 |
| BioInvent International AB | 151 | 1 |
| BioLineRx, Ltd. | 152 | 1 |
| BioSight Ltd. | 153 | 1 |
| Blueprint Medicines Corporation | 154 | 1 |
| Boehringer Ingelheim GmbH | 155 | 1 |
| Boston Biomedical, Inc. | 156 | 1 |
| Bristol-Myers Squibb Company | 157 | 1 |
| Calithera Biosciences, Inc. | 158 | 1 |
| Cancer Therapeutics CRC Pty Ltd | 159 | 1 |
| Cantargia AB | 160 | 1 |
| Cantex Pharmaceuticals, Inc. | 161 | 1 |
| Cascadian Therapeutics Inc | 162 | 1 |
| Celator Pharmaceuticals, Inc. | 163 | 1 |
| Celgene Corporation | 164 | 1 |
| Cellceutix Corporation | 165 | 1 |
| Celldex Therapeutics, Inc. | 166 | 1 |
| Cellectis S.A. | 167 | 1 |
| Cellerant Therapeutics, Inc. | 168 | 1 |
| Celyad SA | 169 | 1 |
| CharlestonPharma LLC | 170 | 1 |
| Constellation Pharmaceuticals, Inc. | 171 | 1 |
| ConverGene, LLC | 172 | 1 |
| Cornerstone Pharmaceuticals, Inc. | 173 | 1 |
| Critical Outcome Technologies Inc. | 174 | 1 |
| CrystalGenomics, Inc. | 175 | 1 |
| CTI BioPharma Corp. | 176 | 1 |
| Cyclacel Pharmaceuticals, Inc. | 177 | 1 |
| Daiichi Sankyo Company, Limited | 178 | 1 |
| DC Prime B.V. | 179 | 1 |
| Debiopharm International SA | 180 | 1 |
| Deciphera Pharmaceuticals, LLC | 181 | 1 |
| DiNonA Inc. | 182 | 1 |
| Eisai Co., Ltd. | 183 | 1 |
| Eli Lilly and Company | 184 | 1 |
| EntreChem, S.L. | 185 | 1 |
| EpiZyme, Inc. | 186 | 1 |
| Erytech Pharma SA | 187 | 1 |
| Esperance Pharmaceuticals, Inc. | 188 | 1 |
| Eureka Therapeutics, Inc. | 189 | 1 |
| Exelixis, Inc. | 190 | 1 |
| F. Hoffmann-La Roche Ltd. | 191 | 1 |
| Fate Therapeutics, Inc. | 192 | 1 |
| FORMA Therapeutics, Inc. | 193 | 1 |
| Formula Pharmaceuticals, Inc. | 194 | 1 |
| Fortress Biotech, Inc. | 195 | 1 |
| Forty Seven Inc. | 196 | 1 |
| Fujifilm Corporation | 197 | 1 |
| Gadeta B.V. | 198 | 1 |
| Galen Limited | 199 | 1 |
| Gamida Cell Ltd. | 200 | 1 |
| Genentech, Inc. | 201 | 1 |
| Genoscience Pharma | 202 | 1 |
| Genosco | 203 | 1 |
| Genzyme Corporation | 204 | 1 |
| Gilead Sciences, Inc. | 205 | 1 |
| GlaxoSmithKline Plc | 206 | 1 |
| GlycoMimetics, Inc. | 207 | 1 |
| Golden Biotechnology Corp. | 208 | 1 |
| H3 Biomedicine Inc. | 209 | 1 |
| Hanmi Pharmaceuticals, Co. Ltd. | 210 | 1 |
| HEC Pharm Co., Ltd. | 211 | 1 |
| Huperion Sarl | 212 | 1 |
| Hybrigenics S.A. | 213 | 1 |
| Igenica Biotherapeutics, Inc. | 214 | 1 |
| Ignyta, Inc. | 215 | 1 |
| Immatics Biotechnologies GmbH | 216 | 1 |
| Immune Pharmaceuticals Inc. | 217 | 1 |
| Immune System Key Ltd. | 218 | 1 |
| ImmunGene, Inc. | 219 | 1 |
| ImmunoGen, Inc. | 220 | 1 |
| Incyte Corporation | 221 | 1 |
| Inflection Biosciences Limited | 222 | 1 |
| Interprotein Corporation | 223 | 1 |
| Jasco Pharmaceuticals, LLC. | 224 | 1 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 225 | 1 |
| Johnson &Johnson | 226 | 1 |
| Juno Therapeutics Inc. | 227 | 1 |
| JW Pharmaceutical Corporation | 228 | 1 |
| Kainos Medicine, Inc. | 229 | 1 |
| Karyopharm Therapeutics, Inc. | 230 | 1 |
| Kiadis Pharma B.V. | 231 | 1 |
| Kolltan Pharmaceuticals, Inc. | 232 | 1 |
| Komipharm International Co., Ltd. | 233 | 1 |
| Kyowa Hakko Kirin Co., Ltd. | 234 | 1 |
| Lead Discovery Center GmbH | 235 | 1 |
| Les Laboratoires Servier SAS | 236 | 1 |
| MacroGenics, Inc. | 237 | 1 |
| Mateon Therapeutics Inc | 238 | 1 |
| MaxCyte, Inc. | 239 | 1 |
| medac GmbH | 240 | 1 |
| MediGene AG | 241 | 1 |
| Medivation, Inc. | 242 | 1 |
| MEI Pharma, Inc. | 243 | 1 |
| Merck &Co., Inc. | 244 | 1 |
| Merus B.V. | 245 | 1 |
| Mesoblast Limited | 246 | 1 |
| Millennium Pharmaceuticals, Inc. | 247 | 1 |
| miRagen Therapeutics, Inc. | 248 | 1 |
| Mirna Therapeutics, Inc. | 249 | 1 |
| Moleculin Biotech, Inc. | 250 | 1 |
| MolMed S.p.A. | 251 | 1 |
| Nanovalent Pharmaceuticals Inc. | 252 | 1 |
| NantKwest, Inc. | 253 | 1 |
| Nemucore Medical Innovations, Inc. | 254 | 1 |
| Nerviano Medical Sciences S.r.l. | 255 | 1 |
| Neumedicines Inc. | 256 | 1 |
| Novartis AG | 257 | 1 |
| NuCana BioMed Limited | 258 | 1 |
| Omeros Corporation | 259 | 1 |
| OncoImmune, Inc. | 260 | 1 |
| Onconova Therapeutics, Inc. | 261 | 1 |
| Oncopeptides AB | 262 | 1 |
| OncoTartis, Inc. | 263 | 1 |
| OncoTherapy Science, Inc. | 264 | 1 |
| Ono Pharmaceutical Co., Ltd. | 265 | 1 |
| Otsuka Holdings Co., Ltd. | 266 | 1 |
| Oxford BioTherapeutics Ltd | 267 | 1 |
| Panther Biotechnology, Inc. | 268 | 1 |
| Pfizer Inc. | 269 | 1 |
| Pharma Mar, S.A. | 270 | 1 |
| Pharmedartis GmbH | 271 | 1 |
| Philogen S.p.A. | 272 | 1 |
| Phylogica Limited | 273 | 1 |
| Plexxikon Inc. | 274 | 1 |
| Polaris Pharmaceuticals, Inc. | 275 | 1 |
| Polyphor Ltd. | 276 | 1 |
| Resverlogix Corp. | 277 | 1 |
| Rich Pharmaceuticals, Inc. | 278 | 1 |
| Sanofi | 279 | 1 |
| Sareum Holdings Plc | 280 | 1 |
| Seattle Genetics, Inc. | 281 | 1 |
| Sellas Inc. | 282 | 1 |
| Selvita S.A. | 283 | 1 |
| Senhwa Biosciences, Inc. | 284 | 1 |
| Shire Plc | 285 | 1 |
| SialoTec GmbH | 286 | 1 |
| Sigma-Tau S.p.A. | 287 | 1 |
| SOM Innovation Biotech SL | 288 | 1 |
| Sorrento Therapeutics, Inc. | 289 | 1 |
| Stemline Therapeutics, Inc. | 290 | 1 |
| Sumitomo Dainippon Pharma Co., Ltd. | 291 | 1 |
| Sunesis Pharmaceuticals, Inc. | 292 | 1 |
| Syndax Pharmaceuticals, Inc. | 293 | 1 |
| SYNIMMUNE GmbH | 294 | 1 |
| Synta Pharmaceuticals Corp. | 295 | 1 |
| Syros Pharmaceuticals, Inc. | 296 | 1 |
| TaiGen Biotechnology Co., Ltd. | 297 | 1 |
| Takeda Pharmaceutical Company Limited | 298 | 1 |
| Targazyme, Inc. | 299 | 1 |
| TetraLogic Pharmaceuticals | 300 | 1 |
| Teva Pharmaceutical Industries Ltd. | 301 | 1 |
| Theravectys SA | 302 | 1 |
| Toko Pharmaceutical Industries Co., Ltd. | 303 | 1 |
| Tolero Pharmaceuticals, Inc. | 304 | 1 |
| Tragara Pharmaceuticals, Inc. | 305 | 1 |
| Trillium Therapeutics Inc. | 306 | 1 |
| Verastem, Inc. | 307 | 1 |
| Vichem Chemie Research Ltd. | 308 | 1 |
| VioQuest Pharmaceuticals, Inc. | 309 | 1 |
| Viralytics Ltd. | 310 | 1 |
| Xencor, Inc. | 311 | 1 |
| Xenetic Biosciences (UK) Limited | 312 | 1 |
| ZIOPHARM Oncology, Inc. | 313 | 1 |
| Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Therapeutics Assessment | 314 | 53 |
| Assessment by Monotherapy Products | 314 | 1 |
| Assessment by Combination Products | 315 | 1 |
| Assessment by Target | 316 | 23 |
| Assessment by Mechanism of Action | 339 | 24 |
| Assessment by Route of Administration | 363 | 2 |
| Assessment by Molecule Type | 365 | 2 |
| Drug Profiles | 367 | 1005 |
| (cytarabine hydrochloride + daunorubicin hydrochloride) Drug Profile | 367 | 11 |
| 1D-11 Drug Profile | 378 | 1 |
| 1J-373 Drug Profile | 379 | 1 |
| 4EGI-1 Drug Profile | 380 | 1 |
| 4G8-SDIEM Drug Profile | 381 | 1 |
| 4SC-202 Drug Profile | 382 | 3 |
| AAG-344 Drug Profile | 385 | 1 |
| AAG-366 Drug Profile | 386 | 1 |
| ABBV-075 Drug Profile | 387 | 1 |
| ACT-001 Drug Profile | 388 | 1 |
| Actimab-A Drug Profile | 389 | 6 |
| ACY-957 Drug Profile | 395 | 2 |
| adarotene Drug Profile | 397 | 1 |
| ADCT-301 Drug Profile | 398 | 1 |
| AEB-1102 Drug Profile | 399 | 2 |
| AF-122 Drug Profile | 401 | 1 |
| AG-120 Drug Profile | 402 | 5 |
| AG-881 Drug Profile | 407 | 1 |
| AGI-14100 Drug Profile | 408 | 1 |
| AGS-67E Drug Profile | 409 | 1 |
| AKN-032 Drug Profile | 410 | 1 |
| AL-8326 Drug Profile | 411 | 1 |
| alpelisib Drug Profile | 412 | 3 |